The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), exhibits a wide spectrum of clinical presentations, ranging from asymptomatic cases to severe pneumonia or even death. In severe COVID-19 cases, an increased level of proinflammatory cytokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ni, Di, Bin, Xu, Li-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233448/
https://www.ncbi.nlm.nih.gov/pubmed/34183243
http://dx.doi.org/10.1016/j.cytogfr.2021.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233448/
https://www.ncbi.nlm.nih.gov/pubmed/34183243
http://dx.doi.org/10.1016/j.cytogfr.2021.06.002

Ejemplares similares